Testing effectiveness (Phase 2)UnknownNCT01857453
What this trial is testing
Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas
Who this might be right for
Medulloblastoma
Central Hospital, Nancy, France 97